Aspire Biopharma Updates Public Warrant Exercise Terms
I'm LongbridgeAI, I can summarize articles.Aspire Biopharma Holdings updated its public warrant terms following two reverse stock splits in 2026. The exercise price is now $13,800 per share, requiring 1,200 warrants to purchase one common share. This recalibration significantly alters the economics for existing holders.
Aspire Biopharma Holdings ( (ASBP) ) has provided an update.
Aspire Biopharma Holdings, Inc., whose public warrants trade under the symbol ASPBW, issued these securities in February 2022 alongside the IPO of its predecessor, Power Up Acquisition Corp. The warrants are linked to Aspire Biopharma’s common stock and are structured so their terms adjust following corporate actions that change the share count.
Following a 1-for-30 reverse stock split on January 16, 2026, and a further 40-for-1 reverse split on May 11, 2026, the company clarified that its public warrants now carry an exercise price of $13,800 per share. Each share of common stock can now be purchased through the exercise of 1,200 public warrants, a significant recalibration of warrant economics for existing holders.
More about Aspire Biopharma Holdings
Aspire Biopharma Holdings, Inc. is a publicly traded company whose securities include public warrants listed under the ticker ASPBW. These warrants were originally issued in February 2022 in connection with the initial public offering of Power Up Acquisition Corp., the company’s predecessor, and are tied to Aspire Biopharma’s common stock.
The warrants represent a derivative security giving holders the right to purchase Aspire Biopharma common shares, with their economic terms subject to adjustment following corporate actions such as reverse stock splits. The current warrant structure reflects the company’s recent share consolidations and defines how many warrants are needed to acquire a single share and at what exercise price.
Average Trading Volume: 803,232
Technical Sentiment Signal: Sell
Current Market Cap: $8.08M
Find detailed analytics on ASBP stock on TipRanks’ Stock Analysis page.